| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/16/1997 | EP0768377A1 Generation and selection of recombinant varied binding proteins |
| 04/16/1997 | EP0768318A2 Peptide having collagen contraction inhibiting activity |
| 04/16/1997 | EP0768317A1 UCK14 compounds |
| 04/16/1997 | EP0768312A2 Bis-Staurosporine and K-252a derivatives |
| 04/16/1997 | EP0768308A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 04/16/1997 | EP0768090A2 Polypeptides having c-AMP producing activity for the prevention of neuronal cell death |
| 04/16/1997 | EP0768043A2 Diabetic nutritional product having controlled absorption of carbohydrate |
| 04/16/1997 | EP0767835A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 04/16/1997 | EP0767833A1 Composition containing collagenase and chymopapain for isolating hepatocytes and pancreatic islet cells |
| 04/16/1997 | EP0767801A1 Endothelin antagonists ii |
| 04/16/1997 | EP0767800A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 04/16/1997 | EP0767799A1 A 24 kilodalton cytoplasmic protease activating dna fragmentation apoptosis |
| 04/16/1997 | EP0767796A1 Monocyte chemotactic protein-4 |
| 04/16/1997 | EP0767677A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 04/16/1997 | EP0767676A1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 04/16/1997 | EP0767675A1 The use of cross-linked hemoglobin in treating subarachnoid hemorrhage |
| 04/16/1997 | EP0767674A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 04/16/1997 | EP0767673A1 Methods for reduced renal uptake of antibody fragments |
| 04/16/1997 | EP0767672A1 Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis |
| 04/16/1997 | EP0767671A1 Method of combating acyclovir-resistant herpes simplex viral infections |
| 04/16/1997 | EP0767668A1 Polynucleoside chain having multiple nucleosides, the nucleosides coupled by guanidyl linkages |
| 04/16/1997 | EP0767667A2 USE OF $g(b)GalNac(1-4)$g(b)Gal CONJUGATES TO TREAT CANDIDA INFECTION |
| 04/16/1997 | EP0767666A1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 04/16/1997 | EP0767661A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 04/16/1997 | EP0651647B1 Glutathione as chemoprotective agent |
| 04/16/1997 | EP0625912B1 Treatment for inflammatory bowel disease |
| 04/16/1997 | EP0609345A4 Biocompatible implant for the timing of ovulation in mares. |
| 04/16/1997 | EP0454782B1 Cancer related haptoglobin (hpr) |
| 04/16/1997 | EP0387290B1 Novel human tissue-type plasminogen activator variant |
| 04/16/1997 | CN1147837A Recombinant adenoviral vector and methods of use |
| 04/16/1997 | CN1147834A Coordinate in vivo gene expression |
| 04/16/1997 | CN1147819A New opioid peptide analogs with mixed MU agonist/delta antagonist properties |
| 04/16/1997 | CN1147768A Compositions comprising DNA damaging agents and P53 |
| 04/16/1997 | CN1147506A Benzoazepine-Benzooxaazepine-Benzothiaazepine-N-acetate derivant |
| 04/16/1997 | CN1034589C Method for producing antitumor antibiotic kedarcidin |
| 04/16/1997 | CN1034588C Improved method for man-promoting growth factor C |
| 04/16/1997 | CN1034577C Producing process for peptides having bradykinin-antagonistic action |
| 04/15/1997 | US5621083 Immunotoxins comprising ribosome-inactivating proteins |
| 04/15/1997 | US5621082 Genetic engineering |
| 04/15/1997 | US5621081 Polypeptide; treatment of nervous system disorders |
| 04/15/1997 | US5621080 A glycoprotein, a polypeptide product, causes bone marrow cells to increase production of reticulocytes and red blood cells |
| 04/15/1997 | US5621079 Produced by culturing cell transformed by expression vector containing selected dna sequence |
| 04/15/1997 | US5621077 Genetic engineering |
| 04/15/1997 | US5621076 Poultry Mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same |
| 04/15/1997 | US5621075 Insulin receptor substrate |
| 04/15/1997 | US5621074 Serine protease inhibitor; reduced nephrotoxicity, stability and positive net charge |
| 04/15/1997 | US5621039 Factor IX- polymeric conjugates |
| 04/15/1997 | US5621001 Methods for administration of taxol |
| 04/15/1997 | US5620987 Amino acid derivatives |
| 04/15/1997 | US5620977 Retroviral protease inhibitors |
| 04/15/1997 | US5620964 Oligosaccharides; eliminating helicobacter from stomach |
| 04/15/1997 | US5620959 Bombesin antagonists |
| 04/15/1997 | US5620958 Bradykinin antagonists |
| 04/15/1997 | US5620957 Hemoregulatory peptides |
| 04/15/1997 | US5620956 Inhibiting differentiation of cytotoxic t-lymphocyte precursor to mature cell specific for foreign antigen |
| 04/15/1997 | US5620955 Synthetic peptide derivatives; inhibit growth of small cell lung cancer or pancreatic cells |
| 04/15/1997 | US5620954 Peptide compositions and uses therefor |
| 04/15/1997 | US5620953 Antiprotozoal cyclic tetrapeptides |
| 04/15/1997 | US5620896 Genetic engineering |
| 04/15/1997 | US5620889 Human anti-Fas IgG1 monoclonal antibodies |
| 04/15/1997 | US5620886 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
| 04/15/1997 | US5620884 Modified polyether |
| 04/15/1997 | US5620881 Comprises at least one amino acid residue substitution or deletion in a segment of a native murine protein |
| 04/15/1997 | US5620867 Isolated dna molecule comprising nucelotide sequence encoding polypeptide having specified amino acid sequence |
| 04/15/1997 | US5620866 Human cripto-related gene |
| 04/15/1997 | US5620858 Method of removing shiga-like toxins from biological samples |
| 04/15/1997 | US5620846 Diagnostic and prognostic indices for cancer and aids |
| 04/15/1997 | US5620706 Polyionic insoluble hydrogels comprising xanthan and chitosan |
| 04/15/1997 | US5620688 Methods of inhibiting the activation of Factor XIII |
| 04/15/1997 | US5620687 Inhibition of intimal hyperplasia using antibodies to PDGF beta receptors |
| 04/15/1997 | US5620685 Protein mixtures containing stem cell factors, interleukins and granulocyte macrophage colony stimulating factors |
| 04/15/1997 | US5620675 Medical diagnosis |
| 04/15/1997 | CA2110410C Therapeutic compositions for osteoinduction |
| 04/15/1997 | CA2104576C A method for the treatment of tumours and sarcomas |
| 04/14/1997 | CA2187482A1 Pharmaceutical composition |
| 04/10/1997 | WO1997012985A2 Multi-functional hematopoietic receptor agonists |
| 04/10/1997 | WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 04/10/1997 | WO1997012979A1 Interleuken-3 (il-3) receptor agonists |
| 04/10/1997 | WO1997012978A1 NOVEL c-mpl RECEPTOR AGONISTS |
| 04/10/1997 | WO1997012977A1 Novel g-csf receptor agonists |
| 04/10/1997 | WO1997012972A2 Regulated genes and uses thereof |
| 04/10/1997 | WO1997012970A1 Antitumour vector constructs and methods |
| 04/10/1997 | WO1997012969A2 Fmr1-related protein |
| 04/10/1997 | WO1997012967A1 Antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for replication |
| 04/10/1997 | WO1997012963A2 A paf-acetylhydrolase and use in therapy |
| 04/10/1997 | WO1997012961A2 Growth of adult pancreatic islet cells with laminin 5 |
| 04/10/1997 | WO1997012914A1 Novel human cc chemokine |
| 04/10/1997 | WO1997012909A1 Novel membrane proteins of helicobacter pylori |
| 04/10/1997 | WO1997012908A1 NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI |
| 04/10/1997 | WO1997012907A1 Peptide inhibitor for viral protease derived from the transframe region of the gag-pol gene |
| 04/10/1997 | WO1997012905A1 Urokinase plasminogen activator fragments |
| 04/10/1997 | WO1997012904A1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/10/1997 | WO1997012903A1 Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012901A1 Process for isolating immunoglobulins in whey |
| 04/10/1997 | WO1997012898A1 Novel platelet activation protein |
| 04/10/1997 | WO1997012894A1 Preparation of glucosaminyl muramic acid derivatives |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012636A2 Bifunctional sulphide-containing sulphonamide s2ny-type chelate-forming agents for radioisotopes |
| 04/10/1997 | WO1997012635A1 Method for treating amyotrophic lateral sclerosis |